Browsing: Mortality Risk

In today’s rapidly evolving insurance landscape, the arrival of AI in Life and Health underwriting and claims workflows is no longer a distant possibility – it’s already a reality.

Griffith Ballard will continue to operate from Cedar Rapids under its existing leadership team.

The past 12 months have seen significant developments that are likely to shape mortality models among defined benefit pensions scheme managers and sponsors alike, and possibly even have an impact on the pricing of de-risking deals.

The broader consequences of climate change are complex and far-reaching, with significant implications for human health, financial systems and the wider economy.

New PRA discussion paper provides insight into the UK regulator’s thinking on potential reforms to the existing ISPV regime.

The past four decades have brought revolutionary improvements in cancer care, transforming many forms of cancer from fatal diagnoses into chronic, manageable conditions.

For those in the longevity and mortality modelling game, 2025 has provided plenty of activity to keep the actuaries busy. Greg Winterton spoke to James Hadley, Senior Consultant at Barnett Waddingham, to learn more about what is front and centre of the conversation in his world as the year draws to a close.

A convergence of themes has contributed to the growth story of the US life and annuity market of the past few years.

The subject of whether life insurance-linked securities (life ILS) structures should be rated or not is a conversation almost as old as the market itself.

The longevity economy is multi-faceted, with a range of investment opportunities available that can impact longevity in different ways. Greg Winterton spoke to Sergey Jakimov, Founding Partner of venture capital firm LongeVC, to get his views on both the space overall, and how LongeVC sees it, and therefore, approaches it in our latest Q&A.